Jabil Inc. Stock News

Louvain-la-Neuve, Belgium, February 25, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial irradiation, and Jabil Inc. a global leader in engineering, manufacturing, and supply chain solutions, announced today they have signed a contract for the installation of a Be-Wide X-ray solution in a ...

ST. PETERSBURG, Fla.--(BUSINESS WIRE)--Apptronik, the AI-powered humanoid robotics company, and Jabil (NYSE: JBL), a global leader in engineering, manufacturing, and supply chain solutions, have announced a pilot and strategic collaboration to build Apollo humanoid robots and integrate them into specific Jabil manufacturing operations. This includes the production lines that will build Apollo h...

NEW YORK--(BUSINESS WIRE)--A consortium of investors led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. today announced they have exited their equity stake in Pharmaceutics International, Inc. (“Pii”), a contract development and manufacturing organization, and have closed on an undisclosed all-cash transaction to sell the company to Jabil Inc....

Jabil's diversification in end markets, particularly Auto & Transportation and Healthcare & Packaging, is driving revenue growth despite a 17% YoY decline in Q1 2025. The company's operational diversification, including a broad geographic footprint and supplier base, provides a competitive edge in managing risks and cost efficiency. Jabil's lack of specialization in specific end markets limits ...

ST. PETERSBURG, Fla.--(BUSINESS WIRE)--Jabil Inc. (NYSE: JBL), a global leader in engineering, manufacturing, and supply chain solutions, today announced the successful acquisition of Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) specializing in early stage, clinical, and commercial volume aseptic filling, lyophilization, and oral solid do...

After analyzing weekly charts of all S&P 500 stocks, I found only 21 with “confidently optimistic” patterns, indicating a challenging market in 2025. My focus is on stocks with better odds of appreciating in 2025, not on beating the S&P 500 or achieving the highest returns. The four stocks I picked out from the crowd —Edwards Lifesciences, Jabil Inc., Kroger, and Darden Restaurants—show strong ...

Shares of contract electronics manufacturer Jabil (JBL -0.41%) have been in fine form over the last few months thanks to its solid quarterly results, and the good news is that the company looks set to enter the new year with momentum on its side following its latest report.

I upgraded JBL to a buy rating, driven by anticipated growth acceleration from AI revenue and strong 1Q25 performance. JBL's 1Q25 revenue was $6.99 billion, surpassing consensus estimates, with AI and Cloud segments showing significant growth. Management's FY25 guidance appears conservative, given AI demand momentum and improving US macro environment.